Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

α-MSH may help treat skin inflammation and fibrosis.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

DFMO may help control hair growth and treat cancer.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Neurosteroids help control dopamine responses in the brain.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.